# Effects of Heme Arginate in Healthy Male Subjects

> **NCT00682370** · PHASE1 · COMPLETED · sponsor: **Daniel Doberer** · enrollment: 15 (actual)

## Conditions studied

- Healthy Subjects
- Heme Oxygenase
- Genetic Polymorphism

## Interventions

- **DRUG:** saline solution
- **DRUG:** heme arginate
- **DRUG:** heme arginate
- **DRUG:** heme arginate

## Key facts

- **NCT ID:** NCT00682370
- **Lead sponsor:** Daniel Doberer
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2013-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00682370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00682370, "Effects of Heme Arginate in Healthy Male Subjects". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00682370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*